Extraction Form Preview:
Phase 1 and 2 trials that looked at the effect of IDH inhibitors in AML patients.
Arm Name Suggestions
No arms specified.
Design Details and Enrollment
Baseline Characteristics Fields
Outcome Name Suggestions
Outcome Title | Note |
---|---|
ORR | |
CR | |
CRi | |
PR | |
ORR/RI40 | |
ORR/RI72 | |
MLFR | |
>1% TEAE | |
Overall Survival. | |
Overall Survival in subjects who had response. |
Outcome Details
Adverse Events
Arm or Total | Title | Description |
---|---|---|
Total |